![Amar Gajjar: SJ901 offers a new targeted therapeutic approach against pediatric low-grade gliomas.](https://oncodaily.com/pub/uploads/2023/09/WhatsApp-Image-2023-09-08-at-20.34.42.jpeg)
Photo of Amar Gajjar and Giles Robinson from their Twitter
Sep 8, 2023, 12:49
Amar Gajjar: SJ901 offers a new targeted therapeutic approach against pediatric low-grade gliomas.
Quoting Amar Gajjar on Twitter:
”SJ901, named after the last 3 digits of the experimental SpringWorks drug, offers a new targeted therapeutic approach against pediatric low-grade gliomas. Giles Robinson.”
For the article click here.
Source: Amar Gajjar/Twitter